|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/24 | |
| A61K 31/505 | |||
| A61K 31/397 |
| (11) | Patento numeris | 2844233 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13785009.5 |
| Europos patento paraiškos padavimo data | 2013-05-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-03-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-05-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/039018 |
| Data | 2013-05-01 |
| (87) | Numeris | WO 2013/166117 |
| Data | 2013-11-07 |
| (30) | Numeris | Data | Šalis |
| 201261641013 P | 2012-05-01 | US |
| (72) |
DIAS, Marie, Charmaine, US
|
| (73) |
Althera Life Sciences, LLC,
1448 89 Headquarters Plaza, Morristown, NJ 07960,
US
|
| (54) | ORAL TABLET FORMULATION CONSISTING OF FIXED COMBINATION OF ROSUVASTATIN AND EZETIMIBE FOR TREATMENT OF HYPERLIPIDEMIA AND CARDIOVASCULAR DISEASES |
| ORAL TABLET FORMULATION CONSISTING OF FIXED COMBINATION OF ROSUVASTATIN AND EZETIMIBE FOR TREATMENT OF HYPERLIPIDEMIA AND CARDIOVASCULAR DISEASES |